BAY 2927088, an oral, reversible tyrosine kinase inhibitor (TKI) that potently inhibits mutant HER2, led to promising response rates when used for the treatment of patients with pretreated HER2 ...
Doctors at Vinmec Times City International Hospital, along with engineers from the 3D Technology in Medicine Center at VinUniversity, have safely and successfully performed a groundbreaking surgery to ...
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...